Sung-Gyu Lee, Vitchan Kim, Gyu-Hyeong Lee, Changmin Kim, Eunseo Jeong, F Peter Guengerich, Donghak Kim
Cytochrome P450 17A1 (CYP17A1) catalyzes 17α-hydroxylation and 17,20-lyase reactions with steroid hormones. Mice contain an orthologous Cyp17a1 enzyme in the genome, and its amino acid sequence has high similarity with human CYP17A1. We purified recombinant mouse Cyp17a1 and characterized its oxidation reactions with progesterone and pregnenolone. The open reading frame of the mouse Cyp17a1 gene was inserted and successfully expressed in Escherichia coli and then purified using Ni-nitrilotriacetic acid (NTA) affinity column chromatography. Purified mouse Cyp17a1 displayed typical Type I binding titration spectral changes upon the addition of progesterone, 17α-OH progesterone, pregnenolone, and 17α-OH pregnenolone, with similar binding affinities to those of human CYP17A1. Catalytic activities for 17α-hydroxylation and 17,20-lyase reactions were studied using ultra-performance liquid chromatography (UPLC)-mass spectrometry analysis. Mouse Cyp17a1 showed cytochrome b stimulation in catalysis. In comparison to human enzyme, much higher specificity constants (k/K) were observed with mouse Cyp17a1. In the reactions of Δ4-steroids (progesterone and 17α-OH progesterone), the specificity constants were 2100 times higher than the human enzyme. The addition of cytochrome b produced significant stimulation of 17,20-lyase activities of mouse Cyp17a1. Two Arg mutants of mouse Cyp17a1 (R347H and R358Q) displayed a larger decrease in 17,20-lyase reaction (from 17α-OH pregnenolone to dehydroepiandrosterone, DHEA) than 17α-hydroxylation, indicating that -as in human CYP17A1-these basic residues in mouse Cyp17a1 are important in interacting with the cytochrome b protein in the lyase reactions.
J Steroid Biochem Mol Biol. 1998 Jan;64(1-2):121-8
[PMID:
9569017]
J Biol Chem. 2014 May 16;289(20):14310-20
[PMID:
24671419]
Nature. 2012 Jan 22;482(7383):116-9
[PMID:
22266943]
Biochim Biophys Acta. 1992 May 8;1125(3):335-40
[PMID:
1596523]
Mol Pharmacol. 1967 Mar;3(2):113-23
[PMID:
4382749]
J Biol Chem. 2014 Nov 21;289(47):32952-64
[PMID:
25301938]
Endocr Rev. 2011 Feb;32(1):81-151
[PMID:
21051590]
J Biol Chem. 2021 Jan-Jun;296:100571
[PMID:
33753170]
N Engl J Med. 2011 May 26;364(21):1995-2005
[PMID:
21612468]
J Steroid Biochem Mol Biol. 2015 Jul;151:52-65
[PMID:
25482340]
Arch Biochem Biophys. 1995 Mar 10;317(2):343-7
[PMID:
7893148]
PLoS One. 2015 Nov 20;10(11):e0141252
[PMID:
26587646]
Biochem Biophys Res Commun. 1982 Sep 16;108(1):379-84
[PMID:
6816231]
Sci Rep. 2020 May 29;10(1):8792
[PMID:
32472014]
Oncologist. 2014 Dec;19(12):1231-40
[PMID:
25361624]
J Biol Chem. 2013 Jun 7;288(23):17008-17018
[PMID:
23620596]
Mol Cell Endocrinol. 2021 May 15;528:111261
[PMID:
33781841]
Cancer. 2014 May 1;120(9):1290-314
[PMID:
24343171]
Arch Biochem Biophys. 2005 Aug 15;440(2):204-11
[PMID:
16055078]
J Biotechnol. 2006 Jun 25;124(1):128-45
[PMID:
16516322]
J Steroid Biochem Mol Biol. 2017 Jun;170:2-18
[PMID:
26976652]
Biochemistry. 1998 Mar 3;37(9):2800-6
[PMID:
9485431]
J Steroid Biochem Mol Biol. 2010 Apr;119(3-5):112-20
[PMID:
20043997]
J Microbiol Biotechnol. 2017 May 28;27(5):983-989
[PMID:
28274101]
Drug Metab Pharmacokinet. 2016 Dec;31(6):445-450
[PMID:
27793475]
J Biol Chem. 2017 Aug 11;292(32):13168-13185
[PMID:
28684414]
Mol Endocrinol. 2016 Apr;30(4):469-78
[PMID:
26974035]
Biochim Biophys Acta. 1991 Jul 30;1084(3):240-6
[PMID:
1888770]
J Investig Med. 2012 Feb;60(2):495-503
[PMID:
22222232]
Biochem Biophys Res Commun. 1999 Dec 29;266(3):690-8
[PMID:
10603307]
Arch Biochem Biophys. 2022 Sep 30;727:109338
[PMID:
35779593]
